Cargando…

Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia A

The main complication of hemophilia A treatment is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). Immune tolerance induction (ITI) is the prescribed treatment for inhibitor eradication, although its working mechanism remains unresolved. To clarify this mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schep, Sarah J., Schutgens, Roger E. G., Fischer, Kathelijn, Voorberg, Jan, Boes, Marianne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061682/ https://www.ncbi.nlm.nih.gov/pubmed/33898928 http://dx.doi.org/10.1097/HS9.0000000000000557

Ejemplares similares

Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis
por: Oomen, Ilja, et al.
Publicado: (2022)

Treatment of acquired hemophilia A, a balancing act: results from a 27‐year Dutch cohort study
por: Schep, Sarah J., et al.
Publicado: (2020)

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia
por: Versloot, Olav, et al.
Publicado: (2022)

Gene Therapy for Hemophilia A: How Long Will It Last?
por: Schutgens, Roger E. G.
Publicado: (2022)

Gene Therapy in Hemophilia: From Hype to Hope
por: Schutgens, Roger
Publicado: (2018)

Immune tolerance induction in patients with severe hemophilia A with inhibitors
por: Ryu, Ji Eun, et al.
Publicado: (2015)

Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study
por: Van Der Valk, Paul, et al.
Publicado: (2022)

Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce
por: Herzog, Roland W., et al.
Publicado: (2017)

The Perspectives of Adolescents and Young Adults on Adherence to Prophylaxis in Hemophilia: A Qualitative Study
por: Hoefnagels, JW, et al.
Publicado: (2020)

The Paediatric Haemophilia Activities List (pedHAL) in routine assessment: changes over time, child‐parent agreement and informative domains
por: Kuijlaars, Isolde A. R., et al.
Publicado: (2019)

Clinical Care of Bone Health in Patients on the Immune Tolerance Induction’s Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia
por: Rezaieyazdi, Zahra, et al.
Publicado: (2020)

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2020)

Catheter Ablation for Atrial Fibrillation in Patients with Hemophilia or von Willebrand Disease
por: van der Valk, Paul R., et al.
Publicado: (2019)

Clinical outcomes in hemophilia: Towards development of a core set of standardized outcome measures for research
por: Dover, Saunya, et al.
Publicado: (2020)

Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
por: Li, Zekun, et al.
Publicado: (2021)

Association between Sports Participation, Factor VIII Levels and Bleeding in Hemophilia A
por: Bukkems, Laura H., et al.
Publicado: (2022)

Innovative Approaches for Immune Tolerance to Factor VIII in the Treatment of Hemophilia A
por: Sherman, Alexandra, et al.
Publicado: (2017)

Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database
por: Versloot, Olav, et al.
Publicado: (2021)

The experiences and attitudes of hemophilia carriers around pregnancy: A qualitative systematic review
por: Punt, Marieke C., et al.
Publicado: (2020)

Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China
por: Li, Zekun, et al.
Publicado: (2019)

Low‐dose immune tolerance induction in children with severe hemophilia A with high‐titer inhibitors: Type of factor 8 mutation and outcomes
por: Sun, Jie, et al.
Publicado: (2022)

Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A
por: ten Ham, Renske M.T., et al.
Publicado: (2022)

Editorial: Role of Metabolism in Regulating Immune Cell Fate Decisions
por: Ohradanova-Repic, Anna, et al.
Publicado: (2020)

The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
por: Qvigstad, Christian, et al.
Publicado: (2018)

Shortening the Haemophilia Activities List (HAL) from 42 items to 18 items
por: Kuijlaars, Isolde A. R., et al.
Publicado: (2021)

Manipulation of Regulatory Dendritic Cells for Induction Transplantation Tolerance
por: Que, Weitao, et al.
Publicado: (2020)

Hepatitis C virus in hemophilia: Health‐related quality of life after successful treatment in the sixth Hemophilia in the Netherlands study
por: Isfordink, Cas J., et al.
Publicado: (2021)

First-line Therapy for Immune Thrombocytopenia: Time for Change
por: Schutgens, Roger E. G.
Publicado: (2022)

The efficacy of the entire-vial dosing of emicizumab: Real-world evidence on plasma concentrations, bleeds, and drug waste
por: Donners, Anouk A.M.T., et al.
Publicado: (2023)

Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
por: Rasekh, Hamid Reza, et al.
Publicado: (2011)

Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes
por: Camelo, Ricardo Mesquita, et al.
Publicado: (2023)

Role of Small Intestine and Gut Microbiome in Plant-Based Oral Tolerance for Hemophilia
por: Kumar, Sandeep R. P., et al.
Publicado: (2020)

Prevention of the anti-factor VIII memory B-cell response by inhibition of Bruton tyrosine kinase in experimental hemophilia A
por: Delignat, Sandrine, et al.
Publicado: (2019)

Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens
por: Grimm, Alizée J., et al.
Publicado: (2015)

Impact of the Induction of Labor on Hemophilia Carriers and Their Newborn Infants
por: Shibahara, Mami, et al.
Publicado: (2021)

Desmopressin in moderate hemophilia A patients: a treatment worth considering
por: Loomans, Janneke I., et al.
Publicado: (2018)

Platelet-Targeted FVIII Gene Therapy Restores Hemostasis and Induces Immune Tolerance for Hemophilia A
por: Cai, Yuanhua, et al.
Publicado: (2020)

Immune tolerance against infused FVIII in hemophilia A is mediated by PD-L1(+) Tregs
por: Becker-Gotot, Janine, et al.
Publicado: (2022)

Novel F8 and F9 gene variants from the PedNet hemophilia registry classified according to ACMG/AMP guidelines
por: Andersson, Nadine G., et al.
Publicado: (2020)

Cd4(+)Cd25(+) Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade
por: Taylor, Patricia A., et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_t9lajhjifr6nt7umrlb714vr6o